Provided by Tiger Trade Technology Pte. Ltd.

ProShares Pet Care ETF

48.31
+0.29790.62%
Post-market: 48.310.00000.00%16:10 EDT
Volume:732
Turnover:35.28K
Market Cap:31.40M
PE:- -
High:48.31
Open:48.29
Low:48.22
Close:48.01
52wk High:57.44
52wk Low:45.96
Shares:650.00K
Float Shares:650.00K
Volume Ratio:0.63
T/O Rate:0.11%
Dividend:0.36
Dividend Rate:0.75%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Oct 07

Halozyme announces Dutch court of the Hague found Merck infringed patents

TIPRANKS
·
Oct 07

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Reuters
·
Oct 07

Halozyme Therapeutics - Iv Version of Keytruda Remains Available and not Covered by Halozyme's Patent or Court Injunction

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Court Rejects Merck's Arguments That Ep622 Patent is Invalid

THOMSON REUTERS
·
Oct 07

Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda Sc in Multiple European Markets

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Court Orders Msd BV to Stop Keytruda Sc Manufacture and Sale in Eight European Countries

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Injunction Forbids Msd from Facilitating Infringement by Affiliates

THOMSON REUTERS
·
Oct 07

Tempus Announces Multi-Year Collaboration with Moderna and Merck

THOMSON REUTERS
·
Oct 07

Will Drug Approvals Change Merck (MRK) Narrative

Simply Wall St.
·
Oct 07

Revvity Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Oct 07

Chewy (CHWY) Following Its Sharp Reset Has A Bullish Fair Value Story

Simply Wall St.
·
Oct 06

Zoetis announces peer-review publication on Simparica Trio

TIPRANKS
·
Oct 06

Zoetis Study Shows Simparica Trio Outperforms NexGard Plus Against Resistant Heartworm Isolate

Reuters
·
Oct 06

Zoetis Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 06

Revvity Inc. Stock Rises 3.8%, Outperforms Peers

Dow Jones
·
Oct 06

Merck & Co Inc Stock (MRK) Moved Down by 3.04% on Oct 5: What Investors Need To Know

TradingKey
·
Oct 05

Merck, Caterpillar Share Losses Lead Dow's 269-Point Drop

Dow Jones
·
Oct 05

JPMorgan Adjusts Price Target on Merck & Co. to $165 From $150, Maintains Overweight Rating

MT Newswires Live
·
Oct 05

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02